Evidence has emerged through clinical trials regarding the use of stem cells in multiple sclerosis (MS) treatment. This evidence shows that transplanting the patients’ stem cells can help create a sustained remission for these MS patients, an autoimmune disease that forces the immune system to attack the body’s central nervous system.

Patients received high-dose immunosuppressive therapy to boost their immune systems and transplanted the stem cells after that therapy. The result five years after this stem cell transplant and immunosuppressive therapy were favorable. Almost 70 percent of the trial’s participants had gone through the experience without any progressions of symptoms, new brain lesions, or relapse.

The most amazing part? These participants also did not take any normal MS medications throughout the five-year process. There are other clinical studies that suggest that these normal MS medications have lower success rates than the lack of medication and stem cell transplant.

This study was conducted by the NIAID-funded Immune Tolerance Network (ITN), sponsored by the National Institutes of Health and the National Institute of Allergy. The final results of the five-year study were published in the medical journal of the American Academy of Neurology, Neurology. The study is shining the light on the potential to give neurologists the ability to help MS patients better than ever before.

One such neurologist is Dr. Shiva Gopal Vasishta, from New Jersey, with more than 40 years under his belt. He graduated from Government Medical College in 1979 and has been a staple in the neurology network ever since. Dr. Gopal Vasishta completed his residency at Boston City Hospital and has built a specialization in Psychiatry.

Dr. Gopal Vasishta has an affiliation with the Kennedy Health System and practices at Eastern Neurodiagnostic Associates. Between new scientific technologies and neurologists like Dr. Gopal Vasishta, a better future can make possible for MS patients.